Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of life

Despite significantly improved survival and response rates in patients diagnosed with multiple myeloma, it still remains an incurable disease with a poor outcome, especially in high-risk groups. Allogeneic stem cell transplantation offers a potentially curative option but remains controversial due t...

Descripción completa

Detalles Bibliográficos
Autores principales: Greil, Christine, Engelhardt, Monika, Ihorst, Gabriele, Schoeller, Katja, Bertz, Hartmut, Marks, Reinhard, Zeiser, Robert, Duyster, Justus, Einsele, Hermann, Finke, Jürgen, Wäsch, Ralph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355495/
https://www.ncbi.nlm.nih.gov/pubmed/30237266
http://dx.doi.org/10.3324/haematol.2018.200881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355495/
https://www.ncbi.nlm.nih.gov/pubmed/30237266
http://dx.doi.org/10.3324/haematol.2018.200881

Ejemplares similares